Screener
Denali Therapeutics Inc. DNLI Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Denali Therapeutics Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Denali Therapeutics Inc.’s 10-Q, filed August 11, 2025. Open the filing →
- Filed
- Aug 11, 2025
- Fiscal quarter
- Q2 FY2025
- Calendar quarter
- Q2 2025
- Accession
- 0001714899-25-000170
FAQ
- What is Denali Therapeutics Inc.'s price / sales?
- Denali Therapeutics Inc. (DNLI) reported price / sales of 2,613.6× in Q2 2024.
- How has Denali Therapeutics Inc.'s price / sales changed year-over-year?
- Denali Therapeutics Inc.'s price / sales increased by 22098.5% year-over-year, from 11.8× to 2,613.6×.
- What is the long-term trend for Denali Therapeutics Inc.'s price / sales?
- Over 3 years (2020 to 2023), Denali Therapeutics Inc.'s price / sales has grown at a -33.5% compound annual growth rate (CAGR), from 30.5× to 9×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about Denali Therapeutics Inc.'s price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude